Nils Olof Bengtsson

Predictive value of p53, mdm-2, p21, and mib-1 for chemotherapy response in advanced breast cancer.

Johanna Sjöström, Carl Blomqvist, Päivi Heikkilä et al. · PubMed · 2000 · 83 citations

Medicine, Cancer Biology, Oncology +15

Tumor-specific VEGF-A and VEGFR2 in postmenopausal breast cancer patients with long-term follow-up. Implication of a link between VEGF pathway and tamoxifen response

L. Ryd�n, Maria Stendahl, H�kan Jonsson et al. · Breast Cancer Research and Treatment · 2005 · 69 citations

Medicine, Endocrinology, Oncology +16

Efficacy and safety of tailored and dose‐dense adjuvant chemotherapy and trastuzumab for resected HER2‐positive breast cancer: Results from the phase 3 PANTHER trial

Alexios Matikas, Nils Olof Bengtsson, Per Malmström et al. · Cancer · 2019 · 26 citations · Full text

Medicine, Oncology, Pharmacology +17

Healthcare resource use, comorbidity, treatment and clinical outcomes for patients with primary intracranial tumors: a Swedish population-based register study

Jenny Bergqvist, Hanna Iderberg, Johan Mesterton et al. · Acta Oncologica · 2016 · 21 citations · Full text

Medicine, Neurosurgery, Oncology +13

Physical Performance, Toxicity, and Quality of Life as Assessed by the Physician and the Patient

Minna‐Liisa Luoma, Liisa Hakamies‐Blomqvist, Johanna Sjöström et al. · Acta Oncologica · 2002 · 13 citations · Full text

Pharmacy, Internal Medicine, Health Assessment +16